← Open Payments lookup

SAMUEL PARMENTER: Open Payments

NPI 1568948313 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$684 in 26 payments from 9 companies in 2025. Trend: 2023 $119 · 2024 $493 · 2025 $684

Food & beverage: $684
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$166
ABBVIE INC.5$160
Otsuka America Pharmaceutical, Inc.5$98
Janssen Pharmaceuticals, Inc5$91
Axsome Therapeutics, Inc.1$77
Alkermes, Inc.1$32
E.R. Squibb & Sons, L.L.C.1$24
Supernus Pharmaceuticals, Inc.1$19
Vanda Pharmaceuticals Inc.1$17

Products named: CAPLYTA, VRAYLAR, REXULTI, SPRAVATO, Auvelity, ARISTADA, COBENFY, Qelbree.

Industry payments across IN — which companies pay providers there.